Health News
Markey Cancer Center at UK gets National Cancer Institute designation, opening up new treatment options for patients
The University of Kentucky annouced Friday that its Markey Cancer Center has earned a prestigious National Cancer Institute designation. With this designation, the center becomes one of 68 in the U.S., and the only one in Kentucky, with special access to clinical trials, new treatments and new drugs for patients.
Kentucky ranks first in the nation in cancer deaths per 100,000 residents, and cancer is especially problematic in Appalachia, where the overall cancer rate is 12 percent higher than in the United States.
The designation signifies national excellence in clinical care and cancer research, a UK news release said. It allows Markey patients to join specialized drug or treatment trials that are open only to NCI centers, and it also opens up funding for researchers at UK, said Michael Karpf, UK's executive vice president for health affairs.
"It's the ultimate recognition for academic cancer centers," Markey Executive Director Mark Evers said. It will help UK battle cancers that plague the state, particularly lung and colorectal cancers, Evers said in a story by Linda Blackford of the Lexington Herald-Leader. To earn the designation, the center had to pass a rigorous review that began four years ago and will be renewed every five years, says the UK release.
UK officials said the designation will boost the state and local economy through research funding, and advanced cancer research could also generate more high-tech, health care jobs in the state. "It strengthens Markey?s reputation as a frontrunner in cancer treatment and research," the UK release said.
-
New Research Building At Uk Will Focus On State's Health Disparities
Artist's rendering of new research centerA new research facility that will focus on addressing the health challenges and disparities in Kentucky is being built on the University of Kentucky's campus and is scheduled to be completed in spring 2018,...
-
New Cancer Treatment For Late Stage Lung Cancer That Was Developed At Uk Is Approved For Clinical Trials
Researchers at the University of Kentucky have pioneered a new medical device for the treatment of late stage lung cancer, which has now been approved for clinical trials by the U.S. Food and Drug Administration at UK, auniversity news release says....
-
Uk Cancer-center Director Urges Lawmakers To Raise Cigarette Tax And Pass A Statewide Smoking Ban To Reduce Cancer Deaths
The Markey Cancer Center at the University of Kentucky supports a statewide smoking ban and an increase in the state cigarette tax to significantly reduce cancer deaths in the state, the center's director told a legislative committee Sept. 3....
-
Uk Nanotechnology Study Shows Promise For More Effective Cancer Treatment Compared To Chemotherapy
Dr. Peixuan Guo, one of the three top nanobiotechnology experts in the worldA new study by University of Kentucky researchers shows promise for developing ultrastable RNA nanoparticles that may help treat cancer and viral infections by regulating cell...
-
Markey Cancer Center At Uk Says Its Patients Have Higher Survival Rates Than Those Treated Elsewhere In Ky. And The Nation
"Patients at the University of Kentucky's Markey Cancer Center who have certain types of cancer have higher rates of survival than patients with the same cancers treated elsewhere in the state or even the nation according to new data released today,"...
Health News